| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |